Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Advancing Myasthenia Gravis (MG) Treatment Through Guideline Updates and Emerging Therapies
October 30, 2025
San Francisco, California
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Robert D. Suh, MD
Lea Azour, MD
Ashwin Basavaraj, MD
Acromegaly Care: Individualized Diagnosis and Management Strategies
July 13, 2025
New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Kendall Moseley, MD
Kenneth G. Saag, MD
First Results From Cohort 4 of the SunRISe-1 Trial
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Nicholas J. Silvestri, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Hans Katzberg, MD
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Trial in Progress: Phase 3 MoonRISe-3 Study
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Darren Brenner, MD
Ocular to Generalized MG: How and Why the Disease Evolves
Diagnostic Advances in gMG: Effective Tools and Techniques
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Mazen Noureddin, MD, MHSc
Evolving Strategies for Sustained-Release Glaucoma Treatments
Sarah H. Van Tassel, MD
Justin Schweitzer, OD, FAAO
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.